Pharmaceutical composition capable of activating blood circulation to dissipate blood stasis, and preparation method thereof

A technology for promoting blood circulation and removing blood stasis and a composition is applied in the field of pharmaceutical compositions for promoting blood circulation and removing blood stasis and the preparation field thereof, which can solve the problems of reduced drug efficacy, side effects, and reduced drug efficacy, and achieves good uniformity and controllability. Low dosage, anticoagulant effect

Active Publication Date: 2018-11-16
HUNAN XINHUI PHARMA
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, the patent application number CN201810218625.3 discloses a traditional Chinese medicine composition for nourishing qi and activating blood circulation and its preparation method. The effect is not good, and there is a problem of side effects. The composition of this invention is composed of Panax notoginseng, pueraria lobata, Chuanxiong, hawthorn, safflower, earthworm, salvia miltiorrhiza, red peony root, angelica, motherwort and astragalus. The above drugs are pulverized and sieved, Decoct the extract, dry and pulverize, and press into tablets.
In this invention, due to the high temperature in the process of processing and storage, active substances such as thrombin will be greatly lost, reducing its efficacy, and the Chinese medicine composition obtained by the preparation method in this invention contains more impurities , the efficacy of the drug will be reduced, and some side effects will occur; all the raw materials are extracted together, and at higher temperatures (usually above 60°C), the raw materials will affect each other, and some of the heat-labile activities The substance is destroyed or lost, and the content of impurities increases, and the side effects are large

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition capable of activating blood circulation to dissipate blood stasis, and preparation method thereof
  • Pharmaceutical composition capable of activating blood circulation to dissipate blood stasis, and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] 1) Take 400g of earthworm biotransformation mycelium, add water and extract once at 60°C, the mass of water added each time is 1600g, the obtained extract is filtered, concentrated at 60°C, freeze-dried, and crushed at low temperature to obtain Dilong Dragon biotransformation mycelium freeze-dried powder;

[0033] 2) Take 400g of Astragalus membranaceus, 200g of Salvia miltiorrhiza, 200g of Chuanxiong and 200g of safflower, add water and extract 3 times at 60°C, the quality of each addition of water is 8000g, then filter, concentrate at 60°C, spray dry to obtain the infusion cream powder;

[0034] 3) Mixing the freeze-dried powder of earthworm biotransformation mycelia and the extract powder to obtain the medicinal composition for promoting blood circulation and removing blood stasis.

Embodiment 2

[0036] 1) Take 600g of earthworm biotransformation mycelia, add water and extract in a vacuum at 50°C for 3 times, the quality of each addition of water is 3600g, the obtained extract is filtered, concentrated in a vacuum at 50°C, and freeze-dried. Low-temperature pulverization to obtain the freeze-dried powder of earthworm biotransformation mycelia;

[0037] 2) Take 600g of Astragalus membranaceus, 300g of Salvia miltiorrhiza, 300g of Chuanxiong and 300g of safflower, add water and extract 3 times at 50°C, each time the mass of water added is 12000g, filter, vacuum concentrate at 50°C, and spray dry to obtain Extract powder;

[0038] 3) Mixing the freeze-dried powder of earthworm biotransformation mycelia and the extract powder to obtain the medicinal composition for promoting blood circulation and removing blood stasis.

Embodiment 3

[0040] 1) Take 800g of earthworm biotransformation mycelium, add water and extract twice at 40°C, the mass of water added each time is 6400g, the obtained extract is filtered, concentrated, freeze-dried, and crushed at low temperature to obtain earthworm biotransformation Mycelium freeze-dried powder;

[0041] 2) Take 800g of Astragalus membranaceus, 400g of Salvia miltiorrhiza, 400g of Chuanxiong and 400g of safflower, add water and extract 3 times at 40°C, each time the mass of water added is 16000g, filter, vacuum concentrate at 40°C, and spray dry to obtain Extract powder;

[0042] 3) Mixing the freeze-dried powder of earthworm biotransformation mycelia and the extract powder to obtain the medicinal composition for promoting blood circulation and removing blood stasis.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition capable of activating blood circulation to dissipate blood stasis, and a preparation method thereof. The pharmaceutical composition comprises the following raw materials by weight: 4-8 parts of the bio-transformed mycelium of earthworms, 4-8 parts of Radix Astragali, 2-4 parts of red sage roots, 2-4 parts of Rhizoma Chuanxiong and 2-4 parts of safflower. The preparation method comprises the following steps: weighing the bio-transformed mycelium of earthworms, adding water, carrying out vacuumized extraction at 40-60 DEG C, and subjecting obtained extract to filtering, concentrating, freeze drying and low-temperature crushing so as to obtain the lyophilized powder of the bio-transformed mycelium of earthworms; weighing Radix Astragali, red sage roots, Rhizoma Chuanxiong and safflower, adding water, carrying out vacuumized extraction at 40-60 DEG C, and then successively carrying out vacuumized concentration and spray-drying so as to obtain extract powder; and mixing the lyophilized powder of the bio-transformed mycelium of earthworms with the extract powder. The prepared pharmaceutical composition has substantial effect on activating blood circulation to dissipate blood stasis, shows higher activity, and can resist myocardial ischemia.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a medicinal composition for promoting blood circulation and removing blood stasis and a preparation method thereof. Background technique [0002] Stroke is the name of a disease in traditional Chinese medicine, and it is also the collective name and common name for acute cerebrovascular diseases. This disease is a group of diseases whose main clinical manifestations are cerebral ischemia and hemorrhagic injury symptoms. , has a very high mortality rate and disability rate, and is mainly divided into two categories: hemorrhagic stroke (cerebral hemorrhage or subarachnoid hemorrhage) and ischemic stroke (cerebral infarction, cerebral thrombosis). The early mortality rate of hemorrhagic stroke is very high. About half of the patients died within a few days of the onset. Although the survivors have been actively treated, most of them still have seque...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/537A61P9/10
CPCA61K36/06A61K36/236A61K36/286A61K36/481A61K36/537A61K2236/331A61K2236/39A61K2236/51A61P9/10A61K2300/00
Inventor 何述金周代俊何承东
Owner HUNAN XINHUI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products